Intellectual Property, Antitrust and Cumulative Innovation in the EU and the US
For decades, the debate about the tension between IP and antitrust law has revolved around the question to what extent antitrust should accept that IP laws may bar competition in order to stimulate innovation. The rise of IP rights in recent years has highlighted the problem that IP may also impede...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | E-Book Buch |
| Sprache: | Englisch |
| Veröffentlicht: |
Oxford
Bloomsbury Publishing (UK)
2012
Hart Publishing Ltd Hart Bloomsbury Publishing Bloomsbury Publishing Plc Hart Publishing |
| Ausgabe: | 1 |
| Schriftenreihe: | Hart Studies in Competition Law |
| Schlagworte: | |
| ISBN: | 9781472561183, 147256118X, 1847319572, 1849463069, 9781847319579, 9781849463065 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | For decades, the debate about the tension between IP and antitrust law has revolved around the question to what extent antitrust should accept that IP laws may bar competition in order to stimulate innovation. The rise of IP rights in recent years has highlighted the problem that IP may also impede innovation, if research for new technologies or the marketing of new products requires access to protected prior innovation. How this ‘cumulative innovation’ is actually accounted for under IP and antitrust laws in the EU and the US, and how it could alternatively be dealt with, are the central questions addressed in this unique study by lawyer and economist Thorsten Käseberg. Taking an integrated view of both IP and antitrust rules — in particular on refusals to deal based on IP — the book assesses policy levers under European and US patent, copyright and trade secrecy laws, such as the bar for and scope of protection as well as research exemptions, compulsory licensing regimes and misuse doctrines. It analyses what the allocation of tasks is and should be between these IP levers and antitrust rules, in particular the law on abuse of dominance (Article 102 TFEU) and monopolisation (Section 2 Sherman Act), while particular attention is paid to the essential facilities doctrine, including pricing methodologies for access to IP. Many recent decisions and judgments are put into a coherent analytical framework, such as IMS Health, AstraZeneca, GlaxoSmithKline (in the EU), Apple (France), Orange Book Standard (Germany), Trinko, Rambus, NYMEX, eBay (US), Microsoft and IBM/T3 (both EU and US). Further topics covered include: IP protection for software, interoperability information and databases; industry-specific tailoring of IP; antitrust innovation market analysis; and the WTO law on the IP/antitrust interface. |
|---|---|
| AbstractList | For decades, the debate about the tension between IP and antitrust law has revolved around the question to what extent antitrust should accept that IP laws may bar competition in order to stimulate innovation. The rise of IP rights in recent years has highlighted the problem that IP may also impede innovation, if research for new technologies or the marketing of new products requires access to protected prior innovation. How this 'cumulative innovation' is actually accounted for under IP and antitrust laws in the EU and the US, and how it could alternatively be dealt with, are the central questions addressed in this unique study by lawyer and economist Thorsten Käseberg.
Taking an integrated view of both IP and antitrust rules - in particular on refusals to deal based on IP - the book assesses policy levers under European and US patent, copyright and trade secrecy laws, such as the bar for and scope of protection as well as research exemptions, compulsory licensing regimes and misuse doctrines. It analyses what the allocation of tasks is and should be between these IP levers and antitrust rules, in particular the law on abuse of dominance (Article 102 TFEU) and monopolisation (Section 2 Sherman Act), while particular attention is paid to the essential facilities doctrine, including pricing methodologies for access to IP.
Many recent decisions and judgments are put into a coherent analytical framework, such as IMS Health, AstraZeneca, GlaxoSmithKline (in the EU), Apple (France), Orange Book Standard (Germany), Trinko, Rambus, NYMEX, eBay (US), Microsoft and IBM/T3 (both EU and US). Further topics covered include: IP protection for software, interoperability information and databases; industry-specific tailoring of IP; antitrust innovation market analysis; and the WTO law on the IP/antitrust interface. For decades, the debate about the tension between IP and antitrust law has revolved around the question to what extent antitrust should accept that IP laws may bar competition in order to stimulate innovation. The rise of IP rights in recent years has highlighted the problem that IP may also impede innovation, if research for new technologies or the marketing of new products requires access to protected prior innovation. How this ‘cumulative innovation’ is actually accounted for under IP and antitrust laws in the EU and the US, and how it could alternatively be dealt with, are the central questions addressed in this unique study by lawyer and economist Thorsten Käseberg. Taking an integrated view of both IP and antitrust rules — in particular on refusals to deal based on IP — the book assesses policy levers under European and US patent, copyright and trade secrecy laws, such as the bar for and scope of protection as well as research exemptions, compulsory licensing regimes and misuse doctrines. It analyses what the allocation of tasks is and should be between these IP levers and antitrust rules, in particular the law on abuse of dominance (Article 102 TFEU) and monopolisation (Section 2 Sherman Act), while particular attention is paid to the essential facilities doctrine, including pricing methodologies for access to IP. Many recent decisions and judgments are put into a coherent analytical framework, such as IMS Health, AstraZeneca, GlaxoSmithKline (in the EU), Apple (France), Orange Book Standard (Germany), Trinko, Rambus, NYMEX, eBay (US), Microsoft and IBM/T3 (both EU and US). Further topics covered include: IP protection for software, interoperability information and databases; industry-specific tailoring of IP; antitrust innovation market analysis; and the WTO law on the IP/antitrust interface. For decades, the debate about the tension between IP and antitrust law has revolved around the question to what extent antitrust should accept that IP laws may bar competition in order to stimulate innovation. The rise of IP rights in recent years has highlighted the problem that IP may also impede innovation, if research for new technologies or the marketing of new products requires access to protected prior innovation. How this 'cumulative innovation' is actually accounted for under IP and antitrust laws in the EU and the US, and how it could alternatively be dealt with, are the central questions addressed in this unique study by lawyer and economist Thorsten K'seberg.Taking an integrated view of both IP and antitrust rules ' in particular on refusals to deal based on IP ' the book assesses policy levers under European and US patent, copyright and trade secrecy laws, such as the bar for and scope of protection as well as research exemptions, compulsory licensing regimes and misuse doctrines. It analyses what the allocation of tasks is and should be between these IP levers and antitrust rules, in particular the law on abuse of dominance (Article 102 TFEU) and monopolisation (Section 2 Sherman Act), while particular attention is paid to the essential facilities doctrine, including pricing methodologies for access to IP.Many recent decisions and judgments are put into a coherent analytical framework, such as IMS Health, AstraZeneca, GlaxoSmithKline (in the EU), Apple (France), Orange Book Standard (Germany), Trinko, Rambus, NYMEX, eBay (US), Microsoft and IBM/T3 (both EU and US). Further topics covered include: IP protection for software, interoperability information and databases; industry-specific tailoring of IP; antitrust innovation market analysis; and the WTO law on the IP/antitrust interface. In this book lawyer and economist Thorsten Käseberg looks at how 'cumulative innovation' is actually accounted for under IP and antitrust laws in the EU and the US, and how it could alternatively be dealt with. |
| Author | Käseberg, Thorsten |
| Author_xml | – sequence: 1 fullname: K seberg, Thorsten |
| BackLink | https://cir.nii.ac.jp/crid/1130000795584283776$$DView record in CiNii |
| BookMark | eNqNkktPGzEUhV31oQLNsvtZFFEkUnz99jJEKURCoirQ7cgz8RAXxw5jTyr-fWcSVERXeHF9JX-2zjnX--hdiMEi9BnwN44ZPtVSAZOECwBF36B9UExS0FySt2j04vAD2lOgFBNa0Y9olNJv3C_JBaZyD13NQ7be2zp3xhc_2ri2bX48KSYhu9x2KRcmLIppt-q8yW5ji3kIcdO3MRQuFHlpi9ntlhna2-tP6H1jfLKjp_0A_fo-u5lejC-vzufTyeXYMMGxHtcKCK8NENUIUmNqNAYGytgFB0JJo3ljQNRaNUwxo7VcEEMqACOZ1QI0PUBfdw-v2_jQ2ZTLlUt1b8UEG7tUQp-GAEa17NHjHWrSvf2TltHnVG68rWK8T-UQ1lN4SryelYOEo_8kbLHahtwaX87OpiAl0ZS9hsRCEzpo_bIjg3Nl7YYKQLcT05wrRhSVUjy7d3frrvIuLV24K9etW5n2sbyY_Lw5296hqkcPd2jlY1ylquuBZzf_vgn9C2Ypr20 |
| ContentType | eBook Book |
| DBID | O~Q RYH 8BJ FQK JBE |
| DEWEY | 343.0721 |
| DOI | 10.5040/9781472561183 |
| DatabaseName | Hart Publishing eBooks CiNii Complete International Bibliography of the Social Sciences (IBSS) International Bibliography of the Social Sciences International Bibliography of the Social Sciences |
| DatabaseTitle | International Bibliography of the Social Sciences (IBSS) |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Law |
| EISBN | 1847319572 9781847319579 9781847319586 1847319580 |
| Edition | 1 1st ed. |
| ExternalDocumentID | 9781847319586 9781847319579 EBC1772934 EBC1069237 BB09960342 HARTB0000738 9781472561183 |
| Genre | Book |
| GroupedDBID | -VX 089 20A 38. A4J AABBV ABARN ABMRC ABOVY ACLGV ACUXZ ADVEM AERRF AERYV AHWGJ AIXPE AJFER ALMA_UNASSIGNED_HOLDINGS ALUEM AMUKE AZZ BBABE BBLSR CZJQH CZZ DUGUG EBSCA ECOWB EEHNK FN4 GMZHJ I4C J-X MYL O~Q PQQKQ PYZUL XI1 ZBOWZ RYH ACMJN 8BJ FQK JBE |
| ID | FETCH-LOGICAL-a46509-c8125ca128f62c03a901418aed51232f95fa16c98f484a997d2a2b11a74e96193 |
| ISBN | 9781472561183 147256118X 1847319572 1849463069 9781847319579 9781849463065 |
| IngestDate | Sun Sep 28 07:23:25 EDT 2025 Tue Apr 15 07:50:05 EDT 2025 Mon Aug 25 08:40:16 EDT 2025 Wed Nov 26 06:01:52 EST 2025 Sat May 31 00:07:34 EDT 2025 Fri Jun 27 00:02:06 EDT 2025 Sat Apr 06 03:43:06 EDT 2024 Wed Nov 12 11:01:09 EST 2025 |
| IsPeerReviewed | false |
| IsScholarly | false |
| LCCallNum | K3850 |
| LCCallNum_Ident | K3850 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-a46509-c8125ca128f62c03a901418aed51232f95fa16c98f484a997d2a2b11a74e96193 |
| Notes | competitionLaw; txt Bibliography: p. [264]-292 Includes index SourceType-Books-1 ObjectType-Book-1 content type line 7 |
| OCLC | 818846983 |
| PQID | EBC1069237 |
| PQPubID | 23473 |
| PageCount | 330 |
| ParticipantIDs | proquest_miscellaneous_1319614397 askewsholts_vlebooks_9781847319586 askewsholts_vlebooks_9781847319579 proquest_ebookcentral_EBC1772934 proquest_ebookcentral_EBC1069237 nii_cinii_1130000795584283776 igpublishing_primary_HARTB0000738 bloomsbury_books_9781472561183 |
| ProviderPackageCode | BBLSR J-X |
| PublicationCentury | 2000 |
| PublicationDate | 2012 2012. 2012-06-08 20120101 |
| PublicationDateYYYYMMDD | 2012-01-01 2012-06-08 |
| PublicationDate_xml | – year: 2012 text: 2012 |
| PublicationDecade | 2010 |
| PublicationPlace | Oxford |
| PublicationPlace_xml | – name: London – name: Oxford |
| PublicationSeriesTitle | Hart Studies in Competition Law |
| PublicationYear | 2012 |
| Publisher | Bloomsbury Publishing (UK) Hart Publishing Ltd Hart Bloomsbury Publishing Bloomsbury Publishing Plc Hart Publishing |
| Publisher_xml | – name: Bloomsbury Publishing (UK) – name: Hart Publishing Ltd – name: Hart – name: Bloomsbury Publishing – name: Bloomsbury Publishing Plc – name: Hart Publishing |
| SSID | ssj0000756037 ssib040194168 |
| Score | 1.9689245 |
| Snippet | For decades, the debate about the tension between IP and antitrust law has revolved around the question to what extent antitrust should accept that IP laws may... In this book lawyer and economist Thorsten Käseberg looks at how 'cumulative innovation' is actually accounted for under IP and antitrust laws in the EU and... |
| SourceID | proquest askewsholts nii igpublishing bloomsbury |
| SourceType | Aggregation Database Publisher |
| SubjectTerms | Anti-trust legislation Antitrust law Antitrust law -- European Union countries Antitrust law -- United States Competition Law Copyright European Law European Union countries Intellectual property Intellectual property -- European Union countries Intellectual property -- United States Intellectual Property Law Law Patent laws and legislation U.S.A |
| SubjectTermsDisplay | Competition Law |
| TableOfContents | Introduction - The Relationship between IP and Antitrust Laws - The Concepts of Monopolisation and Abuse - Refusals to Deal which May Impede Follow-On Innovation - The Licensing Fee - An Essential Facilities Test - Cumulative Innovation under US IP and Antitrust Laws - Cumulative Innovation under European IP Laws and EU Competition Law - Comparison and International Dimension - Summary - Bibliography Intellectual property, antitrust and cumulative innovation in the EU and the US -- Acknowledgements -- Contents -- Abbreviations -- Table of Cases -- Table of Legislation -- 1.Introduction -- 2.The Relationship between IP and Antitrust Laws -- 3.The Concepts of Monopolisation and Abuse: What is the Correct Test? -- 4.Refusals to Deal which May Impede Follow-On Innovation -- 5.The Licensing Fee: Determining Liability and the Remedy -- 6.An Essential Facilities Test -- 7.Cumulative Innovation under US IP and Antitrust Laws -- 8.Cumulative Innovation under European IP Laws and EU Competition Law -- 9.Comparison and International Dimension -- 10.Summary -- Bibliography -- Index. Cover -- Prelims -- Acknowledgements -- Contents -- Abbreviations -- Table of Cases -- Table of Legislation -- 1. Introduction -- 2. The Relationship between IP and Antitrust Laws -- 3. The Concepts of Monopolisation and Abuse: What is the Correct Test? -- 4. Refusals to Deal which May Impede Follow-On Innovation -- 5. The Licensing Fee: Determining Liability and the Remedy -- 6. An Essential Facilities Test -- 7. Cultural Innovation under US IP and Antitrust Laws -- 8. Cumulative Innovation under European IP Laws and EU Competition Law -- 9. Comparison and International Dimension -- 10. Summary -- Bibliography -- Index Prelims -- Acknowledgements -- Contents -- Abbreviations -- Table of Cases -- Table of Legislation -- 1. Introduction -- 2. The Relationship between IP and Antitrust Laws -- 3. The Concepts of Monopolisation and Abuse: What is the Correct Test? -- 4. Refusals to Deal which May Impede Follow-On Innovation -- 5. The Licensing Fee: Determining Liability and the Remedy -- 6. An Essential Facilities Test -- 7. Cultural Innovation under US IP and Antitrust Laws -- 8. Cumulative Innovation under European IP Laws and EU Competition Law -- 9. Comparison and International Dimension -- 10. Summary -- Bibliography -- Index |
| Title | Intellectual Property, Antitrust and Cumulative Innovation in the EU and the US |
| URI | https://doi.org/10.5040/9781472561183?locatt=label:secondary_bloomsburyCollections http://portal.igpublish.com/iglibrary/search/HARTB0000738.html https://cir.nii.ac.jp/crid/1130000795584283776 https://ebookcentral.proquest.com/lib/[SITE_ID]/detail.action?docID=1069237 https://ebookcentral.proquest.com/lib/[SITE_ID]/detail.action?docID=1772934 https://www.vlebooks.com/vleweb/product/openreader?id=none&isbn=9781847319579&uid=none https://www.vlebooks.com/vleweb/product/openreader?id=none&isbn=9781847319586 https://www.proquest.com/docview/1319614397 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZY4WF94ioK2xQQj0TEjR3Hr52CKgEDiRbtLXJuUI2l1bKV_fx9x0mcchGXB14i17Fqy5_j8x37XBh7oSoNHlBJXxud-cJEhZ9llERAFHFgVFZFsrDJJtTJSXx6qj90AR4bm05A1XV8fa03_xVq1AFscp39B7jdn6ICZYCOJ2DH8wdG7H4O1ujOI2RDh-wXbcR_Q6645FvROrFdnduUXVsKF9KnRO3NHZOlM6lcOpr4xt6mi6bsbcEWX9YgjZ0TWXdkYG0vdo8M5n34pF6NhJanRUQ55H-1qUp8560dBRcKDAkqSThID2fTN5sFFOklFBCIe1BiRuw2JGvyzp14gZzgtWr9-Nv-dBd0y_XfRkGlHl9919-YjU1zhm0fIuGyGbN9Mus_b2jdUYzZzxt3ZgeOUK9WP0lWSxcWd9mIXEjusVtlfZ_tvTXfHrD3u-h4PTovPYcNSoU3YOMN2KDoARAvWdo2VFx-fMg-vU4Wx3O_S2bhG0FRCv0cVErmBnygiqZ5EBq6wOaxKQtJtBbfTGV4lOu4ErEwWqtiaqYZ50aJUkPNDR-xUb2uy8fMC7ThuYasKUolyAm2EDKoclnJSMRhNp2w5zuzlW6_2ov3Jm2nWmHXlUr_RaM4mrCjYabToYEDZsKe7c5-umljpKRzqGMzC3oYT9ghIEnzFT053Z-iWktQXwq9pNCJ14OV2kF0dslpMjvmWCTTUP22CSmIocBIXBNskXTvZepyfdWknMQMJ-b95A8jecr2h-_lgI2Af3nI7uTby1VzcdQt6BtF-Xeb |
| linkProvider | ProQuest Ebooks |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=book&rft.title=Intellectual+property%2C+antitrust+and+cumulative+innovation+in+the+EU+and+the+US&rft.au=K%C3%A4seberg%2C+Thorsten&rft.date=2012-01-01&rft.pub=Hart&rft.isbn=9781849463065&rft_id=info:doi/10.5040%2F9781472561183&rft.externalDocID=BB09960342 |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fvle.dmmserver.com%2Fmedia%2F640%2F97818473%2F9781847319579.jpg http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fvle.dmmserver.com%2Fmedia%2F640%2F97818473%2F9781847319586.jpg |
| thumbnail_s | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fportal.igpublish.com%2Figlibrary%2Famazonbuffer%2FHARTB0000738_null_0_320.png |